A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/685 (2006.01) A61K 31/66 (2006.01) A61K 31/661 (2006.01) A61P 25/00 (2006.01) A61P 25/24 (2006.01)
Patent
CA 2352528
An anti-depressant, mental & emotional stress suppressor and mood improver having a prominent action for decreasing blood cortisol level and serotonin reuptake and has an effect of alleviating symptoms associated with depression and mental & emotional stress of a subject administered with the improver. The improver contains as the effective ingredient a combination of phosphatidyl-L-serine and phosphatidic acid, or the salts thereof, comprising at least 200 (w/w) phosphatidyl-L-serine and typically within the range of about 20%-40% of phosphatidyl-L-serine, out of the total phospholipid content of the composition and at least 3% (w/w) of phosphatidic acid, preferably above about 10% and typically within the range of about 20%-40% of phosphatidic acid, out of the total phospholipid content of the composition. The phosphatidyl-L-serine and phosphatidic acid has a structural fatty acid chain derived from at least one raw material lecithin selected from the group consisting of soy bean lecithin, rapeseed lecithin or egg yolk lecithin. Using the raw material lecithin as the substrate, phosphatidyl-L-serine and phosphatidic acid can be produced by enzymatic conversion utilizing phospholipase-D.
Rutenberg David
Fetherstonhaugh & Co.
Lipogen Ltd.
LandOfFree
Phosphatidyl-l-serine and phosphatidic acid composition as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phosphatidyl-l-serine and phosphatidic acid composition as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phosphatidyl-l-serine and phosphatidic acid composition as... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1564574